Search for: "In Re: Fosamax Products Liability Litigation"
Results 81 - 98
of 98
Sorted by Relevance
|
Sort by Date
16 May 2012, 12:22 pm
Feb. 13, 2012); In re Pamidronate Products Liability Litigation, ___ F. [read post]
5 Apr 2012, 11:54 am
Feb. 23, 2012) (express warranty); In re Pamidronate Products Liability Litigation, ___ F. [read post]
6 Mar 2014, 12:41 pm
Accord In re Fosamax Alendronate Sodium Products Liability Litigation, 2013 WL 1558697, at *7-8 (D.N.J. [read post]
12 Dec 2018, 12:38 pm
No discovery means no liability. [read post]
10 Jan 2013, 8:07 am
Food and Drug Administration More Blog Posts: Pharmaceutical Company Allegedly Knew of Harmful Fosamax Side Effects as Far Back as 2004, According to Review of Internal Documents: In Re: Fosamax Products Liability Litigation, Pharmacy Error Injury Lawyer Blog, December 5, 2012 Federal Court Transfers Lawsuit Against Pharmaceutical Company from Washington DC to Ohio, Pharmacy Error Injury Lawyer Blog, September 20, 2012 FDA Warns of Seizure… [read post]
25 Jan 2012, 2:27 pm
” In re Fosamax Products Liability Litigation, 742 F. [read post]
12 Mar 2024, 12:46 pm
Moye from giving such testimony); In re Rezulin Products Liab. [read post]
3 May 2011, 10:20 am
App. 2003); In re Fosamax Products Liability Litigation, 742 F.Supp.2d 460, 471-72 (S.D.N.Y. 2010) (applying Florida law) (all refusing to apply §6(c) in cases involving prescription drugs).It's had somewhat more acceptance in device and vaccine cases where an alternative design requirement at least isn’t physically impossible. [read post]
24 Aug 2015, 5:00 am
McNeil Consumer Healthcare, 615 F.3d 861 (7th Cir. 2010); In re Fosamax, 951 F. [read post]
6 May 2010, 4:12 pm
We think that the recent decision in In re Gadolinium-Based Contrast Agents Products Liability Litigation, MDL No. 1909, slip op. [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol patent… [read post]
15 Jul 2011, 9:20 am
- A review of the new Dukes and AEP (global warming) Supreme Court decisions for how they might apply to drug/device product liability litigation - Link.June 20, 2011: Phony Choices - New Zicam decision distinguishing prescription drug and toxic tort cases with respect to need for dosage information in Daubert causation opinions - Link.June 17, 2011: E-Discovery Fee Shifting? [read post]
1 Oct 2009, 2:14 am
While we're on the subject, can we get judges to rewrite the New Jersey and Minnesota statutes of limitations to add a borrowing statute? [read post]
15 Nov 2009, 6:18 pm
The latest "fad" among defense lawyers — more on the source of the word "fad" in a moment — is to hire companies to monitor state court dockets for suits against big corporations, particularly class actions alleging product liability. [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade Representative over Special 301… [read post]
11 Jul 2008, 4:30 am
Part I – Spicy IP), India: Discussion of grant of Indian patents to Cipla for Fosamax derivative and Nexium derivative: (Spicy IP), India: Draft National Biotechnology Regulatory Authority Bill: (Spicy IP), Ivory Coast: Ivorians increasingly choose fake medicines on price: (Afro-IP), Mexico: New Mexican medicaments approvals regime: an early report: (IP tango), UK: Leave to appeal refused in trade mark infringement proceedings between Eli Lilly and 8PM Chemist concerning the… [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
